OncLive

BCMA-Targeted CAR T-Cell Therapy for Myeloma
OncLive
Transcript: Krishna V. Komanduri, MD: I want to talk about some other diseases beyond the approved indications, and we have some very exciting, I think, preliminary data that we hope to see more about this weekend in the setting of myeloma and AML.

and more »

X